Researchers from the National University of Singapore have identified several potent inhibitors that selectively target FTO, a gene that has been associated with fat mass and obesity in certain people.
Researchers have grown human intestinal tissue from pluripotent stem cells and transplanted the living tissue into mice. These so-called organoids could provide a more accurate model for testing drugs designed to work on the intestines as well as help generate intestinal tissue for new treatments.
By switching on a protein in the heart, scientists may be able to improve recovery in patients that have just endured a heart attack.
A new study appearing in the journal Stem Cell Reports shows that inflammation in pregnant mice causes autism-like symptoms in their offspring.
Investigators have claimed a breakthrough in the amyloid hypothesis, cultivating what they call "Alzheimer's-in-a-dish" that shows deposits of amyloid are indeed to blame for amyloid tangles and brain cell death that lead to the devastating neurodegenerative disease.
Investigators at the University of California, Los Angeles, have found that a drug being studied for a rare genetic disorder called Gaucher disease also appears to slow the progression of Parkinson's disease in mice.
A handful of players are racing to get an Ebola treatment or vaccine to patients as quickly as possible, even though these drugs remain largely untested in humans. We've compiled a list of organizations that are in the global spotlight right now with their investigational Ebola programs.
New technology has allowed researchers to view HIV proteins in action, zooming in on so-called spikes that help the virus bind to cells it infects. The research puts scientists one step closer to a vaccine that could effectively prevent transmission of HIV and halt the spread of AIDS, an international epidemic.
Scientists from Harvard University have developed a technique that coaxes embryonic stem cells into fully functioning human insulin-producing beta cells, possibly paving the way for less invasive and more permanent treatment options for Type 1 diabetes.
New preclinical results from Tetraphase's lead antibiotic candidate are promising in light of rising drug resistance in dangerous bacteria known as superbugs.
Merck Serono is teaming up with London's Institute of Cancer Research and the charitable Wellcome Trust to identify and develop new inhibitors to treat cancer.
President Obama's ambitious BRAIN Initiative--short for Brain Research through Advancing Innovative Neurotechnologies--has awarded its first round of grants, totaling $46 million.
Using a new type of cell transplantation, researchers at Cincinnati Children's Hospital Medical Center corrected a lung disease in mice that mimics a similar rare disease in humans.
Researchers at Rockefeller University are designing a new kind of antibiotic--one that can be programmed to seek out and kill bad bacteria that harbor antibiotic resistance genes while leaving good microbes in tact.
The race to develop an effective vaccine or therapy against the ebolavirus is on, with companies large and small answering the World Health Organization's call to ramp up drug discovery efforts.
The FDA has awarded 15 grants totaling more than $19 million to spur the development of medical devices and drugs to help treat rare diseases.
Swiss firm Mymetics is getting a boost from the Bill and Melinda Gates Foundation to conduct a key animal study for its HIV vaccine candidate at the Texas Biomedical Research Institute.
In an effort to better understand a certain disease-causing enzyme, British researchers have created a "map" of more than 100 proteins this enzyme is known to affect. They then identified a druglike molecule that blocks this enzyme to preserve these essential proteins.
Scientists have figured out how an emerging class of antibiotics binds to the bacterium that causes tuberculosis--a discovery that could lead to new therapeutics to fight the disease, which is becoming resistant to commonly used antimicrobials in many parts of the world.
As the ongoing Ebola outbreak in West Africa worsens, small and large companies alike are touting their investigational drugs in response to the World Health Organization's appeal to speed up research and development in the field.